Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens
Open Access
- 18 January 2010
- journal article
- research article
- Published by Journal of Infection in Developing Countries in Journal of Infection in Developing Countries
- Vol. 4 (04), 218-225
- https://doi.org/10.3855/jidc.634
Abstract
Background: Ventilator-Associated Pneumonia (VAP) is the most frequent intensive-care-unit (ICU)-acquired infection. The aetiology of VAP varies with different patient populations and types of ICUs. Methodology: A prospective study was performed over a period of 15 months in a tertiary care hospital to determine the various aetiological agents causing VAP and the prevalence of multidrug resistant (MDR) pathogens. Combination disk method, Modified Hodge test, EDTA disk synergy (EDS) test and AmpC disk test were performed for the detection of extended spectrum beta-lactamases (ESBL), carbapenemases, metallo-beta-lactamases (MBL) and AmpC β-lactamases respectively. Results: Enterobacteriaceae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Candida spp. were more common in early-onset VAP, while non-fermenters (Pseudomonas spp. and Acinetobacter spp.) were significantly associated with late-onset VAP (P value 0.0267, Chi-square value 4.91). Thirty-seven (78.7%) of the 47 VAP pathogens were multidrug resistant. ESBL was produced by 50% and 67% of Escherichia coli and Klebsiella pneumoniae respectively. MBL was produced by 20% of P. aeruginosa. AmpC beta-lactamases were produced by 33.3% and 60.7% of the Enterobacteriaceae and non-fermenters respectively. Of the S. aureus isolates, 43% were methicillin resistant. Prior antibiotic therapy and hospitalization of five days or more were independent risk factors for VAP by MDR pathogens. Conclusions: VAP is increasingly associated with MDR pathogens. Production of ESBL, AmpC beta-lactamases and metallo beta-lactamases were responsible for the multi-drug resistance of these pathogens. Increasing prevalence of MDR pathogens in patients with late-onset VAP indicate that appropriate broad-spectrum antibiotics should be used to treat them.Keywords
This publication has 8 references indexed in Scilit:
- Ventilator-associated pneumonia in a tertiary care hospital in India: incidence and risk factorsJournal of Infection in Developing Countries, 2009
- Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective studyAnnals of Thoracic Medicine, 2007
- Ventilator-Associated Pneumonia: Diagnosis, Treatment, and PreventionClinical Microbiology Reviews, 2006
- Diagnosis and Treatment of Ventilator-Associated PneumoniaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia-a prospective cohort studyIndian Journal of Critical Care Medicine, 2005
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Diagnosing Pneumonia during Mechanical VentilationAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2002